Guyana vs Latin America and the Caribbean: Proportion of the target population who received 3 doses of
Guyana
98.0%
in 2024
Latin America and the Caribbean
82.0%
in 2024
Guyana rank
23rd
Latin America and the Caribbean rank
20th
Proportion of the target population who received 3 doses of over time
- Guyana
- Latin America and the Caribbean
How they compare
Guyana currently reports 98.0% against 82.0% in Latin America and the Caribbean, a difference of 16.0%.
That makes Guyana's figure about 1.2 times Latin America and the Caribbean's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Latin America and the Caribbean ahead.
Guyana ranks 23rd and Latin America and the Caribbean ranks 20th of 209 countries.
Across the 3 decades both report, Guyana averaged higher in 2 and Latin America and the Caribbean in 1.
Head to head by decade
| Decade | Guyana | Latin America and the Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.6% | 92.3% | 0.7% | Latin America and the Caribbean |
| 2010s | 96.4% | 88.8% | 7.6% | Guyana |
| 2020s | 98.2% | 79.0% | 19.2% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Guyana or Latin America and the Caribbean?
- Guyana, at 98.0% against 82.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Guyana and Latin America and the Caribbean?
- 16.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Latin America and the Caribbean?
- 25 years are reported by both, from 2000 to 2024.
- How do Guyana and Latin America and the Caribbean rank globally for proportion of the target population who received 3 doses of?
- Guyana ranks 23rd and Latin America and the Caribbean ranks 20th of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.